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The Comprehensive Complication Index (CCI1)
Added Value and Clinical Perspectives 3 Years ‘‘Down the Line’’
Pierre-Alain Clavien, MD, PhD, Diana Vetter, MD, Roxane D. Staiger, MD,
Ksenija Slankamenac, MD, PhD, Tarun Mehra, MD,y Rolf Graf, PhD, and Milo Alan Puhan, MD, PhDz
Objective: To explore the added value of the comprehensive complication
index (CCI1) to standard assessment of postoperative morbidity, and to
clarify potential controversies for its application.
Background: The CCI1 was introduced about 3 years ago as a novel metric
of postoperative morbidity, integrating in a single formula all complications
by severity, ranging from 0 (uneventful course) to 100 (death). It remains
unclear, how often the CCI1 adds to standard reporting of complications and
how to apply it in complex postoperative courses.
Methods: CCI1 data were prospectively collected over a 1-year period at our
institution. The proportion of patients with more than 1 complication and the
severity of those complications were assessed to determine the additional
value of the CCI1 compared to the Clavien–Dindo classification. Complex
and controversial cases were presented to 90 surgeons worldwide to achieve
consensus in weighing each postoperative event. Descriptive statistics were
used to evaluate agreement among surgeons and to suggest solutions for
consistent use of the CCI1.
Results: Complications were identified in 24% (290/1212) of the general
surgical population. Of those, 44% (127/290) developed more than 1
complication by the time of discharge, and thereby CCI1 added
information to the standard grading system of complications. Information
gained by the CCI1 increased with the complexity of surgery and observation
time.
Conclusions: The CCI1 adds information on postoperative morbidity in
almost half of the patients developing complications, with particular value
following extensive surgery and longer postoperative observation up to
3 months. Each single complication, independently of their inter-connection,
should be included in the CCI1 calculation to best mirror the patients’
postoperative morbidity.
Keywords: CCI1, classification, comprehensive complication index,
morbidity, score
(Ann Surg 2017;265:1045–1050)
LEARNING OBJECTIVES
After participating in this activity, the reader should be better
able to:
1. Explain the main differences betweenn Clavien-Dindo classifi-
cation and the CCI1.
2. Describe how to use, calculate and interpret the CCI1.
3. Name the added value of complication grading by the CCI1.
Objective and reproducible assessments of postoperative mor-
bidity are central for reliable evaluation of surgical procedures and
quality control.1–3 Quality control has become increasingly import-
ant with the introduction of diagnosis-related group-systems (DRG).
DRGs embrace the total costs including postoperative care. They are
strongly affected by complications that are the strongest driver of
costs.4 Currently, the most widely used grading system of compli-
cations is the Clavien–Dindo classification described in 2004,5
which was reassessed and validated 5 years after its introduction.6
This classification ranks complications by severity based on the
treatment applied to correct each respective complication, and
captures complications within 5 grades. Thereby, the grades under-
standably reflect the magnitude of every single complication. How-
ever, complete tabulation of multiple complications is cumbersome
for readers, and in the majority of studies only the highest grade of
complications is reported. Thus, the Clavien–Dindo classification
may not depict the entire spectrum of postoperative morbidity and
underestimate burden in many studies. In addition, comparisons of
patients with more than 1 complication are difficult; for example,
comparing the morbidities of a patient with 2 grade 3b complications
with another one experiencing 1 grade 4a and 1 grade 1 complication
is not readily possible.
To overcome these shortcomings, a novel metric, the com-
prehensive complication index (CCI1), was developed, integrating
in one single formula all recorded complications weighted by
severity.7 Of note, for the development of the CCI1, both patients
and physicians were asked to rate complication scenarios on a visual
analog scale from 0 to 100. Subsequently, the CCI1was developed in
analogy to the operation risk index used in economic science. This
index is based on the Clavien–Dindo classification and summarizes
the postoperative course with a new morbidity scale ranging from 0
(no complication) to 100 (death). In addition, the CCI1 easily allows
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calculation of postoperative morbidity longitudinally, for example, at
discharge, 3 or 6 months after surgery.7
The value of the CCI1 has been explored in 3 randomized
controlled trials8 showing a greater responsiveness to detect differ-
ences between treatment effects than classical endpoints such as
‘‘any complication’’ or ‘‘major complication’’ defined according to
the Clavien–Dindo classification. This implies that the use of the
CCI1 may significantly decrease the sample sizes in future studies.7
The CCI1 has been used in large multicentric studies,9–17 as a
benchmark endpoint for major surgery,10 or in individual centers to
assess quality and individual surgeon’s performance (Han-Kwang
Yang, ASA 2016, personal communication).
In view of the increased use of the CCI1 in several fields of
surgery, this study targeted several aims: first, to prospectively assess
the additional value of the CCI1 compared with a standard classi-
fication of complications; second, to evaluate in which types of
surgery and for which postoperative observation time the information
gain is greatest. Although simple in theory, its implementation in
daily clinical practice has been shown to be equivocal in complex
clinical situations. Our third aim was, therefore, to clarify the
application of the CCI1 in complex scenarios by presenting con-
troversial cases to a panel of international surgeons and to propose
potential solutions, where no consensus was reached.
METHODS
Assessment of Postoperative Morbidity
The study targeting proper use of the CCI1 in complex cases
at the Department of Surgery, University Hospital Zurich, Switzer-
land, was conducted over a 1-year period (March 2013 to February
2014). Complications were ranked according to the Clavien–Dindo
classification,5 and the CCI1 was calculated at discharge, at 1 and
3 months after surgery. Each case with 1 or more postoperative
complications was routinely discussed at our weekly morbidity and
mortality (M&M) conference, and controversial discussions about
the final ranking of each complication for the calculation of the
CCI1 were recorded. The CCI1 was calculated with an online tool
provided on http://cci.assessurgery.com.
Patients who developed multiple complications served as the
basis to assess the additional value of the CCI1 for the respective
surgical specialties including lower gastrointestinal tract (LGI),
upper gastrointestinal tract, hepato-pancreatico-biliary, transplan-
tation, and general surgery. A distinction was made between minor
and major surgeries, in which minor procedures are defined as
procedures performed without the need of an intermediate care or
an intensive care unit (ICU) such as inguinal hernia repair or colon
(non-rectal) surgery. Major procedures are defined as complex
procedures that require surgical specialization and the availability
of ICU beds, such as esophagectomies, pancreatectomies, or trans-
plant surgery. More detailed information to differentiate minor from
major procedures is available at ([accessed 22. May 2016] http://
www.gdk-cds.ch/fileadmin/docs/public/gdk/themen/hsm/organe/hsm_
finalreport_final_gesamt_inkl_annexe_1–7.pdf).
Online Questionnaire Design
The questionnaire included 4 questions regarding the per-
ceived utility and practicability of the CCI1 from a user point of
view. In addition, 5 complication scenarios, each illustrated by 3
examples, were presented targeting 1) different complications poten-
tially originating from a similar cause, 2) complications induced by
the treatment of another complication, 3) recurrent negative events
interrupted by a period of apparent healing, 4) a single complication
requiring recurrent therapy; for example, multiple relaparotomies,
and 5) postoperative deterioration of a preexisting condition (Suppl
Table 1, http://links.lww.com/SLA/B169).
The 5 scenarios were submitted to each attending member of
the Department of Surgery at the University Hospital Zurich and sent
to a panel of international surgeons (n ¼ 147) via an online ques-
tionnaire. Most of the contacted surgeons were involved in previous
publications of the Clavien–Dindo classification system or familiar
with the CCI1; they were predominantly members of the European
Surgical Association. If no response was received, a reminder was
sent by email 4 and 8 weeks after the initial invitation. All responses
within 3 months after the initial contact were included in the analysis.
When no consensus was found by the evaluation of the questionnaire,
a proposition for potential consensus was made based on multiple
discussions at the weekly M&M conferences at the Department of
Surgery, University Hospital Zurich.
Statistical Analysis and Ethical Approval
Results of the CCI1 and the survey were analyzed using
descriptive statistics. The additional value of the CCI1 was further
assessed as a function of operation type (major vs. minor; surgical
specialty) and time over a period of 3 months after surgery. In case of
non-Gaussian distribution of our data, the Friedman Test was used
to test for statistical significance. P values <0.05 were regarded
statistically significant. We performed all analyses using GraphPad
Prism 6.07, GraphPad Software Inc, La Jolla, CA. This study was
covered by the approval of the institutional review board of the
Canton Zurich, Switzerland (KEK-ZH-Nr.2016-00231). Informed
consent was not necessary, as the analysis was donewith anonymous,
routine clinical data from our hospital. Patient data were anonymized
and deidentified prior to analysis.
RESULTS
Postoperative Morbidity and Multiple
Complications
During the study period, 1667 patients were admitted to the
Department of Surgery at the University Hospital Zurich, of whom
290 (24%) developed at least 1 complication during hospitalisation.
The distribution of complications according to the Clavien–Dindo
classification is shown in Figure 1. Forty-four percent (127/290) of
the patients developed more than 1 complication by the time of
discharge. Patients with higher grades in the Clavien–Dindo
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FIGURE 1. The proportion of patients presenting with 1 single
complication versus those with multiple complications .
Percent refers to the proportion of patients who developed
more than 1 complication.
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classification also had a higher number of complications. For
example, while only 8% of patients with a grade 1 complication
had more than 1 complication, 73% of patients with a grade 4a
complication developed multiple complications (Fig. 1). In order to
directly compare the postoperative burden captured by the Clavien–
Dindo classification and the CCI1, we calculated the median CCI1
considering only the highest complication (ie, according to the
Clavien–Dindo classification) versus considering all complications.
Three months postoperatively, the median CCI1 in patients with
complications taking into account the highest complication was
26.2 [25th–75th percentile 20.9–33.7], whereas this figure increased
to 33.5 [20.9–46.6] when considering all complications.
Further, we evaluated whether the ranking of complications
changed if morbidity was summarized by the CCI1 in comparison to
the Clavien–Dindo score. After the complication categorization into
quartiles, we found that 2% of patients fell into a lower quartile when
using the CCI1 and 24% into a higher one.
Postoperative Morbidity Based on Complexity and
Type of Surgery
Fifty-three percent (71/133) of patients after major surgery
developed more than 1 complication, as compared with 36% (56/
157) after minor procedures (Table 1). More specifically, 63%
(46/73) of patients with complications after liver, kidney, or pancreas
transplantation had more than 1 complication, whereas only 14% of
patients undergoing less complex surgeries, including nephrectomies
or shunt procedures, developed multiple complications (Table 1).
Similarly, 60% of patients with complications after extensive LGI
surgery had more than 1 complication, while this was the case in only
38% (26/69) of patients undergoing less complex LGI procedures
(Table 1).
Longitudinal Assessment of Postoperative
Morbidity
The median CCI1 (25–75th percentile) significantly
increased from 25.1 (20.9 – 33.7) at discharge to 27.9 (20.9 –
39.7) at 3 months after surgery (P <0.01). The overall percentage
of patients with more than 1 complication increased from 44%
(127/290) at discharge to 57% (170/296) at 3 months after surgery.
Evaluation of CCI
W
From a User Point of View
The response rate of the online questionnaire was 55%
(90/165). Forty-two percent of the responding surgeons reported
routine use of the CCI1, while 27% declared occasional use and 31%
did not yet use the CCI1. Eighty-one percent of the participants
considered the ability to assess longitudinal and long-term morbidity
as one of the main advantages of the CCI1. Another 83% of the
participants agreed that the minimum follow-up after surgery should
be 3 months. Regarding the ideal application field of the CCI1, 72%
of the surgeons would not limit the use of the CCI1 to major
procedures only.
Clinical Scenarios
Scenario 1: Related Complications
All 3 examples covering the first scenario illustrated compli-
cations that were related to each other, that is, originating from the
same cause. Each complication was considered an individual com-
plication by the majority of participants (agreement 76%–85%)
(Fig. 2; Suppl Table 1, http://links.lww.com/SLA/B169). For
example, the pancreatic fistula leading to subsequent fascial dehis-
cence required 2 distinct therapies for correction. Consequently, both
therapies are considered additive events for the calculation of the
CCI1 by most of the surveyed participants.
Scenario 2: Complications Caused by a Therapy of a
Prior Complication
The majority of participants considered complications that
occurred as a consequence of the treatment of another event as
distinct complications that need to be computed separately (agree-
ment: 73%–87%) (Fig. 2, Suppl Table 1, http://links.lww.com/SLA/
B169). For example, most participants rated a pancreatitis after
TABLE 1. Complications (n) at Discharge Listed According to Subspecialty, Number of Complications, and Complexity of
Surgery
Overall, n (%) Major Surgery, n (%) Minor Surgery, n (%)
1 Compl 2 Compl 1 Compl 2 Compl 1 Compl 2 Compl
Total 163 127 (44%) 62 71 (53%) 101 56 (36%)
Tx 33 47 (59%) 27 46 (63%) 6 1 (14%)
LGI 47 32 (41%) 4 6 (60%) 43 26 (38%)
UGI 33 19 (37%) 18 7 (28%) 15 12 (44%)
HPB 24 25 (51%) 12 12 (50%) 12 13 (52%)
General 26 4 (13%) 1  25 4 (14%)
compl indicates complication; general, general surgery; HPB, hepatopancreaticobiliary; Tx, transplant; LGI, lower gastrointestinal tract; UGI, upper gastrointestinal tract.
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FIGURE 2. The results of the survey disclosing the percent of
participants who rated each complication separately. The 3
examples (example 1 , example 2 , and 3 D) for each
scenario enable to assess the survey–participant agreement.
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ERCP performed to treat a bile leak after hepatectomy as 2 distinct
complications. Participants clearly favored the patients’ perspective
by acknowledging the additional burden associated with each type
of complication.
Scenario 3: Two Similar Complications at an Interval
In the situation of a recurrent complication with intermittent
phases of apparent healing, the responses of participants were less
consistent. For example, recurrent high output stoma was considered
1 single complication by the majority of participating surgeons
(72%), whereas only 46% of the participants considered recurrent
ulcer bleeding occurring 2 and 4 months after surgery as 1 compli-
cation. Similarly, there was no clear consensus on how to rate a
recurrent subileus with 54% of the responders considering such
events as 1 complication (Fig. 2, Suppl Table 1, http://links.lww.
com/SLA/B169).
Likewise, discussions on different examples of similar
scenarios were controversial at the M&M conferences. Based on
the discussion records from the M&M conferences, the decision
whether such complications should be rated as 1 single or 2 distinct
complications depends on whether a complete healing occurred
between both episodes. A proposition on how to rate these scenarios
will follow in the discussion (Table 2).
Scenario 4: Complications Requiring Repetitive
Interventions
Consistent with the consensus of the 5-year follow-up of the
Clavien–Dindo classification,6 the majority of participants counts
repetitive treatments of 1 single complication only once (Fig. 2).
Whether a complication recurred at the same or different locations,
for example, recurrent abscesses at different locations after open
necrosectomy due to necrotizing pancreatitis, had no impact on the
judgment of participants. Interpretation of the 3 examples at the
M&M conference or by members of the University of Zurich
provided opposite opinion with more than 60% of the participants
counting those events as separate complications. Planned second
looks due to 1 disease were, however, predominantly considered 1
complication (87%) (Fig. 2, Suppl Table 1, http://links.lww.com/
SLA/B169). The consensus proposal will be presented in the dis-
cussion section (Table 2).
Scenario 5: Postoperative Deterioration of Preexisting
Conditions
There was a consensus that postoperative deterioration of a
preexisting morbidity should be regarded as a complication (Fig. 2,
Suppl Table 1, http://links.lww.com/SLA/B169). For example, 85%
of responding surgeons considered deterioration of renal insuffi-
ciency with subsequent need of dialysis as a complication. Further,
94% of participants rated myocardial postoperative infarction in a
patient with known coronary heart disease as a complication. Inter-
estingly, postoperative reonset of preoperatively existing intermittent
atrial fibrillation requiring antiarrhythmic therapy, was considered a
complication by 78% of externally asked surgeons, but only by 33%
of staff members of the Department of Surgery at the University
Hospital Zurich. The latter group reasoned that the intermittent atrial
fibrillation was preexistent and should therefore be considered
persistence of a preoperative morbidity. A proposal for how to handle
those scenarios is presented below (Table 2).
DISCUSSION
In this study, we demonstrated the added value of the CCI1 to
the tabulated complications listed by severity with a need to record
both approaches, at least following major surgeries. Morbidity
should be consistently reported at 3 months after surgery for all
procedures. The other main message was to clarify how to use the
CCI1 in complex postoperative courses.
The widely used tabulated form of reporting postoperative
complications by the Clavien–Dindo system is based on the type of
therapy required to treat the complication. This system is an
objective, simple, reliable, and reproducible way of reporting
negative events after many types of surgery.6 Although this classi-
fication allows the complete reporting ofmultiple complications in a
patient, this approach is undoubtedly cumbersome to interpret.
In fact, many centers using the Clavien–Dindo classification
focus only on the most severe complication. Thus, a limitation of
this classification is that events of lesser severity may not be
considered, leading to an underestimation of the true overall
postoperative morbidity.
This is where the additional use of the CCI1 comes into play.
The CCI1 facilitates comparisons of patients with more than one
complication, as all postoperative events including their respective
severity are taken into account for its calculation. As an appealing
facet of the formula, it offers a ‘‘common sense’’ scale ranging from 0
(uneventful course) to 100 (death).
During an observation period of 12months, 44% (127/290) of
patients with complications after abdominal surgery developed
more than one postoperative complication. Thus, the CCI1 offers
additional information on morbidity in about half of the patients
with a complicated course. The information gain depends on
the extent and specialty of surgery. Moreover, there was an associ-
ation between the number of complications and time after surgery as
the percentage of patients with postoperative complications devel-
oping more than one complication increased from 44% at discharge
to 57% three months after surgery. This study therefore highlights
the need to collect data on postoperative morbidity for at least
3 months after surgery, which is in line with previously published
studies.10,18,19
In many areas surrounded by controversies regarding defi-
nitions, grading of events, or equivocal data, a consensus approach
may offer solutions leading to wider acceptance.20–22 Such a con-
sensus was achieved by evaluating difficult clinical situations after
the initial introduction of the Clavien–Dindo classification.6 We felt
that a similar exercise is justified 3 years after the introduction of the
CCI1 due to its increasing use in retrospective, prospective, and
benchmark studies.10 Perhaps the CCI1 will become a standard
endpoint in the benchmark evaluation of a variety of surgeries.
Therefore, early consistent use of the CCI1 is paramount to ensure
comparability of data among studies in the future. For this purpose,
scenarios representing cases identified as equivocal during the M&M
conference were sent to surgeons worldwide for assessment. An
TABLE 2. Proposed Consensus on How to Rate Complex
Complication Scenarios for CCI1 Calculation
Complication Scenario Proposed Consensus
for CCI1 Calculation
Complication caused by another
complication
¼ two complications
Complications caused by a therapy
applied to treat another complication
¼ two complications
Two similar complications at an interval ¼ two complications
One Complication requiring repetitive
interventions
¼ separate complications
Planned second look ¼ one single complication
Postoperative deterioration of a
preexisting morbidity
¼ one complication
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overall consensus was documented for scenarios describing either
complications originating from the same cause, or from the treatment
of another complication, as well as events resulting from the
deterioration of preexisting conditions. A summary of the final
recommendations is presented in Table 2.
Of note, 2 scenarios failed to reach a consensus with the
international survey, namely how to grade repetitive intervention to
correct 1 single complication or recurrent complications after appa-
rent intermittent healing (scenarios 3 and 4). From the patients’
perspective, postoperative morbidity is clearly higher for events
requiring multiple interventions, compared with a single one. The
proposed consensus is to consider recurrent episodes as distinct
complications and to count each intervention separately for CCI1
calculation, with the exception of ‘‘planned’’ second look operations.
The main argument for this exception is to avoid surgeons denying
‘‘second look’’ laparotomies to minimize their recorded morbidity by
CCI1. Second, patients requiring multiple planned second looks are
prone to be on the ICU with an overall high postoperative compli-
cation rate. This will be captured anyway by the CCI1 through
monitoring of other complications.
To secure standardization in the use of the CCI1, and particu-
larly for proper grading of complications, frequently asked questions
are available on http://assessurgery.com/about_cci-calculator. A
mobile and tablet version is also ready to use (http://cci.assessurger-
y.com) for the calculation of the CCI1 by entering the respective
Clavien–Dindo complication grades per patient.
This study has some limitations. As the CCI1 is based on the
Clavien–Dindo classification, there is no improvement regarding the
interuser reliability of the new scoring system. However, the repro-
ducibility of the Clavien–Dindo classification was previously shown
to be high.5 Further, the CCI1 does not include risk adjustment for
preoperative morbidity. The CCI1 is exclusively a marker for post-
operative morbidity. Patients in high-volume centers are more likely
to present with significant comorbidities and will therefore be more
prone to develop a higher CCI1. It is clear that comorbidities must be
included in any objective risk-adjusted comparison.
Of note, not every undesirable postoperative event should be
considered a complication. There are two others types of negative
outcome.23 Any unavoidable consequence of a procedure, referred to
as ‘‘sequela’’, differs from a complication by its predictability. For
example, the inability to walk after a leg amputation is a sequel, not
a complication. Also ‘‘failure to cure’’ - describing the failure
of achieving the goal of an intervention - is not a postoperative
complication, e.g. a R2 resection, while the aim of surgery was a
curative resection.23
In conclusion, the CCI1 has been shown to yield a substantial
additional value to the Clavien–Dindo classification in patients with
more than 1 complication. Especially after major surgery and with
inclusion of the observation time after surgery, its value increases.
This, however, does not justify a replacement of 1 system by the other
as the Clavien–Dindo classification discloses the highest grade of
complications and the type of complications. Therefore, in future
studies both systems should be routinely used for recording post-
operative studies following the recommendations and propositions
made above on the use of the CCI1.
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